# Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)

> **NCT03314207** · — · COMPLETED · sponsor: **Beacon Therapeutics** · enrollment: 14 (actual)

## Conditions studied

- X-Linked Retinitis Pigmentosa

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03314207
- **Lead sponsor:** Beacon Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2022-02-10
- **Final completion:** 2022-02-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03314207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03314207, "Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03314207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*